文献

J-GLOBAL ID：200902283203454507   整理番号：05A0482883

III型高リポ蛋白質血症は進行性全身性アテローム性動脈硬化症を伴うSheehan症候群によって強められる 28年間の臨床経過

Type III Hyperlipoproteinemia Exaggerated by Sheehan’s Syndrome With Advanced Systemic Atherosclerosis A 28-Year Clinical Course

著者 (11件)： KAWASHIRI Masa-aki (Molecular Genetics of Cardiovascular Disorders, Div. of Cardiovascular Disease) ,  HIGASHIKATA Toshinori (Molecular Genetics of Cardiovascular Disorders, Div. of Cardiovascular Disease) ,  TAKATA Mutsuko (Molecular Genetics of Cardiovascular Disorders, Div. of Cardiovascular Disease) ,  KATSUDA Shoji (Molecular Genetics of Cardiovascular Disorders, Div. of Cardiovascular Disease) ,  MIWA Kenji (Molecular Genetics of Cardiovascular Disorders, Div. of Cardiovascular Disease) ,  NOHARA Atsushi (Dep. of General Medicine, Kanazawa Univ. Hospital) ,  INAZU Akihiro (School of Health Sci., Fac. of Medicine) ,  KOBAYASHI Junji (Dep. for Life-style-related Diseases, Graduate School of Medical Sci.s, Kanazawa Univ.) ,  SHIMIZU Masami (Molecular Genetics of Cardiovascular Disorders, Div. of Cardiovascular Disease) ,  KOIZUMI Junji (Dep. of General Medicine, Kanazawa Univ. Hospital) ,  MABUCHI Hiroshi (Molecular Genetics of Cardiovascular Disorders, Div. of Cardiovascular Disease)
資料名： Circulation Journal  (Circulation Journal)
巻： 69  号： 6  ページ： 746-751 (J-STAGE)  発行年： 2005年 
JST資料番号： F0908A  ISSN： 1346-9843  資料種別： 逐次刊行物 (A)
記事区分： 短報  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： 38歳の日本人女性が全身性黄色腫の詳細な検査のために入院した...

シソーラス用語： *高リポタンパク質血症 ,...
準シソーラス用語： Sheehan症候群

   続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=05A0482883&from=J-GLOBAL&jstjournalNo=F0908A") }}

分類 (1件)： 代謝異常・栄養性疾患一般  (GD05010J)

物質索引 (1件)： コレステロール

引用文献 (22件)：

• 1. Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerotic disease: New perspectives based on the Framingham study. Ann Intern Med 1979; 90: 85-91.
• 2. Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D. Serum cholesterol, blood pressure, and mortality: Implications from a cohort of 361,662 men. Lancet 1986; 2: 933-926.
• 3. Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience): Prospective Cardiovascular Munster study. Am J Cardiol 1992; 70: 733-737.
• 4. Mahley RW, Rall SC Jr. Type III hyperlipoproteinemia (dysbetalipoproteinemia): The role of apolipoprotein E in normal and abnormal lipoprotein metabolilsm. <i>In:</i> Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic & molecular bases of inherited disease, 8^th edn. New York: McGraw-Hill; 2001; 2835-2862.
• 5. Schneider WJ, Kovanen PT, Brown MS, Goldstein JL, Utermann G, Weber W, et al. Familial dysbetalipoproteinemia: Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows. J Clin Invest 1981; 68: 1075-1085.

タイトルに関連する用語 (4件)： III型高リポ蛋白質血症 ,  全身性アテローム性動脈硬化症 ,  Sheehan症候群 ,  臨床経過